NCT01232959

Brief Summary

Today there are three different ways to remove a gallbladder with gallstones. Surgeons can remove the gallbladder through small incisions in the abdomen. This is called laparoscopic cholecystectomy. It is the current standard. It has replaced traditional open gallbladder surgery. Open gallbladder surgery is done with a large incision. A new way of removing the gallbladder in women is through the vagina. This is called transvaginal cholecystectomy. This study is being done to see if removing the gallbladder through the vagina will work for patients at Mayo Clinic Rochester. This is the first step of this research to test the procedure. In the future, other studies will examine the potential for less scarring and reduced pain. In this study the investigators will still make small incisions in the abdomen, they will be smaller than the standard procedure but you will still have some scars on your abdomen. Some very early research reports say that some patients may have less pain with the transvaginal approach; however, the investigators do not know if the transvaginal route will have any effect on your overall health and quality of life. This study will evaluate:

  • Effectiveness of the surgery: ability to remove the gallbladder safely
  • Effect of the operation on your body: change in pulse and blood pressure during the surgery, level of inflammation markers in your blood before and after the surgery
  • Recovery from surgery in the hospital: how much pain you have, how much pain medication you need, how long you need to stay in the hospital, or nature of any surgical complications (problems)
  • Overall recovery from surgery: general quality of life, abdominal symptoms What is the new type of surgery? The new type of surgery is called transvaginal cholecystectomy: A small incision is made in the vagina. An endoscope (flexible lighted camera tube) is inserted into the abdomen. An endoscope is normally used to examine your stomach or colon. A very small camera is placed in your abdomen at the belly button (5 mm, ¼ inch). This helps the surgeons to remove your gallbladder through the vagina. The procedure to separate your gallbladder from your body will be assisted by instruments placed through your abdomen and instruments placed in your vagina. The surgeon will remove the gallbladder by passing it though your vagina.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2010

Typical duration for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 2, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

January 13, 2016

Status Verified

January 1, 2016

Enrollment Period

2.2 years

First QC Date

October 28, 2010

Last Update Submit

January 12, 2016

Conditions

Keywords

Gallbladder removal

Outcome Measures

Primary Outcomes (1)

  • Feasibility measured by successful transvaginal removal of gallbladder

    The procedure will be considered technically successful if at completion the cystic duct and artery have been clipped securely and the gallbladder has been removed through the transvaginal port. At the time of surgery, the procedure will be supervised with a laparoscope at all critical points. Conversion to a laparoscopic or open procedure is considered an incomplete transvaginal procedure.

    1 year

Secondary Outcomes (3)

  • Safety and tolerability measured by individual and overall Adverse Events

    Following each surgery but overall at 1 year

  • Pain Scores as measured on the Visual Analog Scale

    1 year

  • Quality of Life measured through validated questionnaires

    1 year

Study Arms (1)

Transvaginal Surgery

EXPERIMENTAL

Gallbladder will be removed through the vagina

Device: Transvaginal Cholecystectomy

Interventions

A small incision is made in the vagina. An endoscope (flexible lighted camera tube) is inserted into the abdomen. An endoscope is normally used to examine your stomach or colon. A very small camera is placed in your abdomen at the belly button (5 mm, ¼ inch). This helps the surgeons to remove your gallbladder through the vagina. The procedure to separate your gallbladder from your body will be assisted by instruments placed through your abdomen and instruments placed in your vagina. The surgeon will remove the gallbladder by passing it though your vagina.

Also known as: gallbladder removal
Transvaginal Surgery

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients undergoing elective cholecystectomy for cholelithiasis.

You may not qualify if:

  • Male patients, patients \<18 years or \>65 years of age
  • Pregnant patients
  • Patients with prior pelvic surgery
  • Patients with prior hepatobiliary surgery or other major abdominal surgery
  • Patients with ASA class \>3
  • Patients with BMI \>35
  • Patients with risk factors for requiring an open cholecystectomy (e.g. possible gallbladder cancer, acute cholecystitis, jaundice)
  • Patients who cannot provide consent for the study
  • Patients not willing to participate in the study.
  • Patients with common bile duct stones
  • Patients with evidence of abdominal abscess or mass
  • Patients with diffuse peritonitis
  • Patients with a clinical diagnosis of sepsis
  • Patients with coagulopathy or using anticoagulants or anti-platelet agents (aspirin up to 81mg/day acceptable)
  • Patients with planned concurrent procedures
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gallstones

Interventions

Cholecystectomy

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Biliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Juliane Bingener-Casey, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

October 28, 2010

First Posted

November 2, 2010

Study Start

October 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

January 13, 2016

Record last verified: 2016-01